We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter Offers Latest Innovations in Urinalysis and Automation at AACC 2021

By LabMedica International staff writers
Posted on 27 Sep 2021
Print article
Image: DxA 5000 Fit Workflow Automation System (Photo courtesy of Beckman Coulter)
Image: DxA 5000 Fit Workflow Automation System (Photo courtesy of Beckman Coulter)

Beckman Coulter, Inc. (Brea, CA, USA) displayed its latest innovations in urinalysis and automation that are designed to improve lab workflow at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.

AACC 2021 was a live event held at the Georgia World Congress Center in Atlanta on September 26-30. At this year’s AACC Clinical Lab Expo, more than 700 exhibitors displayed the latest diagnostic technology, including but not limited to mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation. Beckman Coulter introduced its latest urinalysis solutions that continue to build upon its Iris legacy.

Beckman Coulter showcased its iRICELL series of automated walk-away workcells that delivers maximum efficiency and productivity for low- to high-volume labs. The iRICELL series combines urine chemistry and microscopy in a fully automated, walk-away workcell that is easy to use and maintain. It allows labs to optimize and advance urinalysis and body fluid testing with the company’s proprietary Digital Flow Morphology technology that uses Auto-particle Recognition (APR) software to deliver standardized and accurate results.

Beckman Coulter also highlighted its iQ200 series designed for low- to high-volume workloads, automating sample microscopy and producing shortened TAT. By leveraging its proprietary Digital Flow Morphology technology using Auto-Particle Recognition (APR) Software, urine particles are isolated, identified and characterized on the screen to virtually eliminate the need for manual microscopy. The iQ200 series analyzers are available as either stand-alone instruments or they can be connected to an iChemVELOCITY urine chemistry analyzer to form an automated iRICELL workcell.

Also on display at the event was Beckman Coulter’s iChemVELOCITY, a fully automated urine analyzer that provides results for ascorbic acid levels in samples. The iChemVELOCITY sets the standard for automated urine chemistry analysis with the development of the ascorbic acid test pad to identify possible ascorbic acid interference with key chemistry assays, ensuring laboratories receive clinically relevant information. This urine chemistry instrument offers high throughput of up to 210 samples per hour and ease of use to maximize lab performance and productivity.

Beckman Coulter also introduced the newest connection to DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than 5,000 tests a day. The DxA 5000 Fit is designed for laboratories with space constraints, yet, its scalable design allows it to easily expand to accommodate growing workloads. With the DxA 5000 Fit, mid-sized labs can enjoy the same benefits as larger-volume labs.

Related Links:
Beckman Coulter, Inc.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article
ADLM

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.